Regarding hyperventilation in intracranial pressure management, which statement is true?

Regarding hyperventilation in intracranial pressure management, which statement is true?

• A. Hyperventilation to 25 mm Hg PaCO2 is recommended for long-term lowering of ICP
• B. PaCO2 around 30-35 mm Hg is effective for short-term ICP lowering
• C. Hyperventilation has no effect on ICP
• D. PaCO2 should always be kept above 40 mm Hg

Answer: (B)

Lowering PaCO2 leads to cerebral vasoconstriction, which reduces cerebral blood volume and lowers intracranial pressure. This effect happens quickly but is temporary, so mild hyperventilation is used as a short-term, temporizing measure rather than a long-term strategy. Targeting a PaCO2 around 30–35 mmHg can acutely lower ICP, while more aggressive lowering (such as down to 25 mmHg) increases the risk of cerebral ischemia and isn’t recommended for long-term management. Keeping PaCO2 above 40 mmHg would raise cerebral blood flow and worsen ICP. Thus, the statement that PaCO2 around 30–35 mmHg is effective for short-term ICP lowering reflects the proper, time-limited use of hyperventilation in this context.

Lowering PaCO2 leads to cerebral vasoconstriction, which reduces cerebral blood volume and lowers intracranial pressure. This effect happens quickly but is temporary, so mild hyperventilation is used as a short-term, temporizing measure rather than a long-term strategy. Targeting a PaCO2 around 30–35 mmHg can acutely lower ICP, while more aggressive lowering (such as down to 25 mmHg) increases the risk of cerebral ischemia and isn’t recommended for long-term management. Keeping PaCO2 above 40 mmHg would raise cerebral blood flow and worsen ICP. Thus, the statement that PaCO2 around 30–35 mmHg is effective for short-term ICP lowering reflects the proper, time-limited use of hyperventilation in this context.